BCART — Biocartis NV Share News
0.000.00%
Last trade - 00:00HealthcareBalancedMicro Cap
Brief: Biocartis Launch Of Rapid CE-marked IVD Idylla GeneFusion Panel For Fast Treatment Decisions In Lung Cancer
Brief: Biocartis Publishes New Study On Idylla GeneFusion Assay
Brief: Biocartis Q1 Product Revenue Up At EUR 10.1 Mln
Brief: Euronext Announces Annual Review Of Bel Family Indices
Brief: Biocartis FY Total Operating Income Down At Eur 54.9Mln
Brief: Biocartis And Ophiomics To Collaborate On Liver Cancer Test
Biocartis jumps after positive results on rapid-test for lung cancer patients
Rapid EGFR Testing With Idylla Alongside NGS Has Potential To Enhance Lung Cancer Patient Health Outcomes
'Balanced risk/reward profile', Kepler cuts Biocartis to 'hold'
Brief: Biocartis End-Dec Cash Position Amounts To EUR 53.5 Mln
Brief: Biocartis Detects Omicron Variant With Idylla™ SARS-CoV-2 Testing
Brief: Biocartis Says FDA Grants 510(K) Clearance For Septicyte® RAPID
Brief: Biocartis: Publication Of New Study On Idylla EGFR Mutation Test
Brief: Biocartis Group Confirms Targets For 2021
Brief: Biocartis: Restart Of High-Throughput Cartridge Manufacturing Line
Brief: Biocartis H1 Operating Loss Widens To 33.1 Million Euros
Brief: Biocartis Launches Idylla SARS-CoV-2/Flu/RSV Panel
Brief: Biocartis: Impact Of Fire May Compromise SARS-CoV-2 Testing Volumes
French and Benelux stocks-Factors to watch